Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial
- PMID: 34069621
- PMCID: PMC8160847
- DOI: 10.3390/ijerph18105439
Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial
Abstract
(1) Background: Stress, anxiety, and depression have been identified as factors that influence the development of inflammatory bowel disease (IBD). The main aim of this study was to test the effectiveness of group multicomponent cognitive-behavioral therapy at reducing stress, anxiety, and depression, and improving quality of life and the clinical course of the disease. (2) Methods: A total of 120 patients were evaluated using the General Perceived Stress Scale, Scale of Stress Perceived by the Disease, the anxiety and depression scale, and quality of life questionnaire for patients with IBD. Disease activity was measured using the Mayo Index for ulcerative colitis and CDAI for Crohn's disease, as well as the number of relapses self-reported by patients. Patients were randomized to receive group multicomponent cognitive-behavioral therapy or treatment as usual. (3) Results: The psychological intervention reduced stress (EAE: 45.7 ± 8.8 vs. 40.6 ± 8.4, p = 0.0001; PSS: 28.0 ± 7.3 vs. 25.1 ± 5.9, p = 0.001) and improved quality of life (164.2 ± 34.3 vs. 176.2 ± 28.0, p = 0.001). An improvement was found in the number of relapses self-reported by patients (0.2 relapses/patient vs. control 0.7 relapses/patient; p = 0.027). No differences were found in disease activity indexes. (4) Conclusions: Psychological therapy was associated with improved stress, quality of life and with a decrease in the number of relapses self-reported by patients. Clinical trial registration number: NCT02614014.
Keywords: disease activity; inflammatory bowel disease; psychological intervention.
Conflict of interest statement
The authors declare that no conflict of interest exist.
Figures
Similar articles
-
Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.Gastroenterology. 2019 Mar;156(4):935-945.e1. doi: 10.1053/j.gastro.2018.11.030. Epub 2018 Nov 16. Gastroenterology. 2019. PMID: 30452919 Clinical Trial.
-
A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease.Therap Adv Gastroenterol. 2022 Sep 27;15:17562848221127238. doi: 10.1177/17562848221127238. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36187365 Free PMC article.
-
A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease.Inflamm Bowel Dis. 2016 Mar;22(3):694-701. doi: 10.1097/MIB.0000000000000629. Inflamm Bowel Dis. 2016. PMID: 26529560
-
Mindfulness-Based Interventions in Inflammatory Bowel Disease.Gastroenterol Clin North Am. 2017 Dec;46(4):859-874. doi: 10.1016/j.gtc.2017.08.008. Epub 2017 Oct 3. Gastroenterol Clin North Am. 2017. PMID: 29173527 Review.
-
Psychological factors associated with inflammatory bowel disease.Br Med Bull. 2021 Jun 10;138(1):16-28. doi: 10.1093/bmb/ldab010. Br Med Bull. 2021. PMID: 34057462 Free PMC article. Review.
Cited by
-
Effects of psychological stress on inflammatory bowel disease via affecting the microbiota-gut-brain axis.Chin Med J (Engl). 2025 Mar 20;138(6):664-677. doi: 10.1097/CM9.0000000000003389. Epub 2025 Feb 18. Chin Med J (Engl). 2025. PMID: 39965932 Free PMC article. Review.
-
The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease-A Cross-Sectional Pilot Study.Life (Basel). 2021 Dec 5;11(12):1347. doi: 10.3390/life11121347. Life (Basel). 2021. PMID: 34947878 Free PMC article.
-
Psychological burden and quality of life in newly diagnosed inflammatory bowel disease patients.Front Psychol. 2024 Jan 29;15:1334308. doi: 10.3389/fpsyg.2024.1334308. eCollection 2024. Front Psychol. 2024. PMID: 38348263 Free PMC article.
-
Effectiveness and safety of non-pharmacological therapies for the treatment of inflammatory bowel disease: a network meta-analysis.Front Med (Lausanne). 2025 Jun 30;12:1593483. doi: 10.3389/fmed.2025.1593483. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40662074 Free PMC article.
-
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update.Rev Recent Clin Trials. 2022;17(3):156-170. doi: 10.2174/1574887117666220628151256. Rev Recent Clin Trials. 2022. PMID: 35770406
References
-
- Acosta M.B.-D., Marín-Jiménez I., Panadero A., Guardiola J., Cañas M., Montoya M.G., Modino Y., Alcaín G., Bosca-Watts M.M., Calvet X., et al. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad inflamatoria intestinal. Gastroenterol. Hepatol. 2018;41:118–127. doi: 10.1016/j.gastrohep.2017.10.003. - DOI - PubMed
-
- Humbel F., Rieder J.H., Franc Y., Juillerat P., Scharl M., Misselwitz B., Schreiner P., Begre S., Rogler G., von Kanel R., et al. Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in Remission. Clin. Gastroenterol. Hepatol. 2020;18:2019–2029. doi: 10.1016/j.cgh.2019.09.022. - DOI - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical